Status:
NOT_YET_RECRUITING
Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access
Lead Sponsor:
Centre Hospitalier Intercommunal Robert Ballanger
Conditions:
Internal Medicine
Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In certain cases (e.g.: patient who are difficult to perfuse, thin veins, etc.), an increase in venipunctures performed by study nurses in healthcare services can lead to a loss of venous capital, rep...
Detailed Description
This research evaluates the importance of assessing the venous capital access of hospitalized patients prior to the placement of an intravenous infusion, in order to save time in initiating therapeuti...
Eligibility Criteria
Inclusion
- Male and Female Adult Patients Aged 18 Years and Older
- written informed consent given by patient
- Affiliation to a social security system or equivalence system
Exclusion
- Patients in Intensive Care Units
- Patients with Psychiatric Disorders or Under Psychiatric Care
- Minor Patients Under 18 Years of Age
- Pregnant or Breastfeeding Women
- Vulnerable and Protected Individuals as Defined by the Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2)
- Patients Participating in Another Interventional Study
- Dying patients
- Patients Receiving Infusions of:
- Chemotherapy Drugs with a pH \<5 or \>8
- Solutions with an Osmolarity \>900 mOsm/L
- Patients refusing to participate in the study
Key Trial Info
Start Date :
April 21 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06952829
Start Date
April 21 2025
End Date
September 1 2028
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Robert Ballanger
Aulnay-sous-Bois, France, 93602